# OnCo record takeda (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/takeda/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "takeda" ;
  schema:name "Takeda"@en ;
  schema:alternateName "Millennium Pharmaceuticals"@en, "Ariad Pharmaceuticals"@en, "ARIAD"@en, "Nycomed"@en, "Shire"@en ;
  schema:description "Takeda co-owns Adcetris outside the US and is developing STING-agonist conjugates and CAR-NK cells."@en ;
  schema:url <https://onco.cc/companies/takeda/>, <https://www.takeda.com> ;
  schema:dateModified "2026-09-04"^^xsd:date ;
  schema:citation <https://www.takeda.com> ;
  schema:addressCountry "JP" ;
  onco:sections <https://onco.cc/fronts/adcs/>, <https://onco.cc/fronts/immunotherapy/> ;
  onco:drugs <https://onco.cc/drugs/brentuximab-vedotin/>, <https://onco.cc/drugs/tak-928/>, <https://onco.cc/drugs/elritercept/>, <https://onco.cc/drugs/sapanisertib/>, <https://onco.cc/drugs/serabelisib/>, <https://onco.cc/drugs/human-normal-immunoglobulin/> ;
  onco:companies <https://onco.cc/companies/takeda-ventures/> ;
  onco:trials <https://onco.cc/trials/nct04129502/>, <https://onco.cc/trials/nct06390995/>, <https://onco.cc/trials/nct05020015/>, <https://onco.cc/trials/nct02979522/>, <https://onco.cc/trials/nct07648030/>, <https://onco.cc/trials/nct07436728/>, <https://onco.cc/trials/nct06980480/>, <https://onco.cc/trials/nct02716116/>, <https://onco.cc/trials/nct05673785/>, <https://onco.cc/trials/nct07205718/> .